To access this element change to forms mode OFF
Grant Award View - GA67181
Retinoid X receptors and Rexinoids: Harnessing their Neuroprotective...
GA ID:
GA67181
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
20-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$652,052.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
Retinoid X receptors and Rexinoids: Harnessing their Neuroprotective effects in the Glaucoma
Purpose:
Glaucoma causes blindness and despite our best treatment many patients continue to progress. A new approach is needed to protect the cells that die in the retina. We have established that a protein Retinoid X receptor (RXR) plays an important role in the retina, and its activation is protective. We aim to modulate RXRs using ocular gene therapy and pharmacological approaches and demonstrate that this target can be used as a novel therapy in glaucoma.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1188552
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Macquarie University
Recipient ABN:
90 952 801 237
Grant Recipient Location
Suburb:
Macquarie Park
Town/City:
Macquarie Park
Postcode:
2113
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA